Anisha Mazloom - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Critical Care Explorations|April 27, 2023

Implementing Pediatric Surviving Sepsis Campaign Guidelines: Improving Compliance With Lactate Measurement in the PICUAnisha Mazloom, Stacey M Sears, Erin F Carlton, et al.

Molecular Pharmacology|August 18, 2012

Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirsWenchang Guo, Ruiwu Liu, Yoko Ono, et al.

EJNMMI Research|February 29, 2016

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumorsWenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.

Pediatrics|September 22, 2023

Ensuring No Death Is Ignored: Development of a Hospital Mortality Review and Notification SystemKatherine E Bates, Bethany Freeland, Kathryn L Levy, et al.

Plos One|August 23, 2013

CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitorsWenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Critical Care Explorations|April 27, 2023

Implementing Pediatric Surviving Sepsis Campaign Guidelines: Improving Compliance With Lactate Measurement in the PICUAnisha Mazloom, Stacey M Sears, Erin F Carlton, et al.

Molecular Pharmacology|August 18, 2012

Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirsWenchang Guo, Ruiwu Liu, Yoko Ono, et al.

EJNMMI Research|February 29, 2016

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumorsWenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.

Pediatrics|September 22, 2023

Ensuring No Death Is Ignored: Development of a Hospital Mortality Review and Notification SystemKatherine E Bates, Bethany Freeland, Kathryn L Levy, et al.

Plos One|August 23, 2013

CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitorsWenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, et al.

Pageof 1